Nasus Pharma Ltd. (NSRX) is a publicly traded the market company. As of September 14, 2026, NSRX trades at $3.33 with a market cap of $39.88M and a P/E ratio of 0.00. NSRX moved -2.23% today. Year to date, NSRX is -55.23%; over the trailing twelve months it is -59.94%. Its 52-week range spans $1.98 to $9.99. Rallies surfaces NSRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks NSRX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $3.33 |
| Market Cap | $39.88M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.99 |
| 52-Week Low | $1.98 |
| Volume | 3.57K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
NSRX analyst coverage data. Average price target: $0.00.